How Google plans to detect heart attacks and cancer
Google is developing a pill containing nanoparticles and a wristband to diagnose diseases in the body

A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
Google is developing a pill containing nanoparticles that can roam the human body to diagnose cancer or an impending heart attack.
The search giant announced its plans at a tech conference yesterday in a bid to find new partners for the project.
Dr Andrew Conrad, a molecular biologist who previously developed a cheap HIV test, is leading the project at the company's experimental research lab Google X, which has previously worked on self-driving cars and contact lenses for patients with diabetes. So how would the new technology work and does it pose any risks?
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What is a nanoparticle?
It is a tiny piece of matter that can occur naturally or by design. The particles are so small they are measured in nanometres, one of which is one billionth of a metre, or one millionth of a millimetre.
What would Google use them for?
In theory, the user would ingest the nanoparticles, which would be programmed to attach themselves to any cancerous cells or fatty plaques that might cause a heart attack or stroke. Another type of nanoparticle might monitor chemicals in the blood to detect problems such as kidney disease, which is linked to high levels of potassium in the blood. Google wants to develop software, worn as a wristband, that could take readings from the nanoparticles via light and radio waves and make a diagnosis. Dr Conrad says the company's "dream" is that the system will be used for every test normally carried out by a doctor.
How long before it works?
Will Oremus at Slate says the word "dream" seems appropriate. "Intriguing as the concept is, there's an awful lot that still has to go right for Google to pull off something like this." The company has to develop the technology, but also faces a much higher regulatory bar than conventional diagnostic tools if users are to ingest it. Nevertheless, Google has employed 100 people from areas including astrophysics, chemistry and electrical engineering to work on the project. One radiology doctor advising the company says they are around five to seven years away from a product approved for use by doctors.
What are the drawbacks?
A pill that collects information from inside your body raises "maximum privacy concerns", says Tech Times. "Google is not exactly known for keeping its users' information private and was hugely criticised for handing over user information to US government agencies in previous years." Google insists it will not collect people's medical information or attempt to commercialise it, but simply license the technology to partners, enabling doctors and patients to use it as a medical device.
BBC health editor James Gallagher says Google will also have to address concerns around "false positives", when healthy people are told they are ill, as well as the issue of "over-diagnosis" when treatment is sometimes not needed despite a condition being discovered. "Screening the body for disease is littered with dangers," says Gallagher, "and if it is not done carefully, it could make hypochondriacs out of all of us."
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
-
A reckoning over looted art
The Explainer Thousands of artifacts in U.S. and European collections were stolen from their countries of origin. Should they be sent back?
By The Week Staff Published
-
A surge in surge pricing
Feature And more of the week's best financial insight
By The Week Staff Published
-
Rupert Murdoch steps aside at the empire he built
Feature The last of the old-style 'press barons' has retired. What is he leaving behind?
By The Week Staff Published
-
Is using Google's Enhanced Safe Browsing mode worth it?
Talking Point The mode has its positives and its drawbacks
By Justin Klawans Published
-
Google is pitching an AI journalism tool to major news outlets
Talking Point News executives find the technology called Genesis unsettling
By Theara Coleman Published
-
Forget junk mail. Junk content is the new nuisance, thanks to AI.
Speed Read AI-generative models are driving a surge in content on fake news sites
By Theara Coleman Published
-
Why hasn't Google enforced its policy to stop climate disinformation?
Talking Point Is Google's acceptance of climate misinformation intentional?
By Devika Rao Published
-
AI can now read your mind, researchers report as the 'godfather of AI' quits to warn about his life's work
Speed Read
By Peter Weber Published
-
AI: Google seeks to regain lost ground
feature Once a leader in the artificial intelligence wars, the company is now sweating its comeback
By The Week Staff Published
-
AI and Big Tech: busted flush or next gold rush?
Talking Point Generative AI start-ups won $1.37bn in investment last year – almost as much as the five previous years combined
By Arion McNicoll Published
-
The Supreme Court, Section 230 and the future of the internet
feature Lawsuits brought against tech giants could have far-reaching consequences for the internet as we know it
By Richard Windsor Published